Canada markets closed

MYND Life Sciences Inc. (MYNDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07290.0000 (0.00%)
At close: 10:03AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0729
Open0.0729
BidN/A x N/A
AskN/A x N/A
Day's Range0.0729 - 0.0729
52 Week Range0.0729 - 1.1000
Volume22,000
Avg. Volume349
Market Cap3.42M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    MYND Life Sciences Announces Chief Scientific Officer, Dr. Wilf Jefferies, Induction as a National Academy of Inventors Fellow

    Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, is pleased to announce that Dr. Wilfred Jefferies, Mynd's Chief Scientific Officer, has been inducted as a Fellow of the National Academy of Inventors. Globally, the most accomplished inve

  • Newsfile

    MYND Life Sciences Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins

    Vancouver, British Columbia--(Newsfile Corp. - June 1, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, today announced positive preclinical data in measuring dosing accuracy in psilocybins and psilocybin analogs.Mynd strives to improve industry standards and promotes innovative research appr

  • Newsfile

    MYND Life Sciences Announces $3.5 Million Share Offering

    Vancouver, British Columbia--(Newsfile Corp. - April 21, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), is pleased to announce that it plans to undertake a non-brokered private placement offering (the "Offering") of common shares in share capital of the Company ("Shares") to raise gross proceeds of a minimum of $3,000,000 up to $3,500,000, or such other amounts as may be determined by the Company.The Offering will close immediately after (and ...